First Human Gets New Antibody Aimed At Hepatitis C Virus

A Phase 1 clinical trial of a human monoclonal antibody that neutralizes the hepatitis C virus (HCV) has begun. The trial will include 30 healthy volunteers and will test the safety and activity of the monoclonal antibody. More than 3.2 million Americans are chronically infected with HCV, which attacks the liver and can lead to liver failure, killing 10,000 annually.

Read the whole article on Science Daily

More from Science Daily